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The number of patent tibial vessels does not
influence primary patency after nitinol stenting of
the femoral and popliteal arteries
Jenny J. Lee, MD,a and Steven G. Katz, MD,b Pasadena and Los Angeles, Calif
Objective: Initial TransAtlantic Inter-Society consensus (TASC) II classification has been shown to influence the patency
of stented femoral and popliteal arteries. Although several studies have shown the effect of the number of runoff vessels
on the durability of infrainguinal angioplasty without stenting, the influence of tibial vessel runoff on the patency of
primarily stented femoral and popliteal arteries has not been as well defined. The purpose of this study was to determine
whether the number of patent tibial vessels affects primary patency after primary stenting of the femoral and popliteal
arteries.
Methods: The records of all patients undergoing angioplasty and primary nitinol stenting of the femoral and popliteal
arteries, by or under the supervision of one vascular surgeon, were reviewed. Results were analyzed by both the number
of patent tibial vessels documented on periprocedural angiography and by using a modified Society for Vascular Surgery
runoff score. TASC II classification was also recorded. Kaplan-Meier survival curves were plotted and differences between
groups tested by log-rank method. Fisher exact and 2 tests were used to compare categoric factors.
Results: During a 7-year period, 289 limbs in 236 patients underwent primary stenting of the femoral and popliteal
arteries. Overall primary patency was 70.3% at 12 months, 52.4% at 24 months, and 39.1% at 36 months. Limbs classified
as TASC A or B had significantly better patency rates than those classified as TASC C or D (P< .001). While the number
of runoff vessels decreased with worsening of the TASC classification (P  .024), overall (P  .355), and within
individual TASC classes (P> .092 for each), there was no difference in the primary patency of stented segments with good
runoff and those with compromised runoff. Limbs with poor runoff (one or no vessels) were no more likely to fail with
occlusion than their counterparts with two or three patent tibial vessels (P  .383). The number of patent tibial vessels
at the time of initial stenting did not impact ultimate limb salvage (P  .063).
Conclusions: The number of patent tibial vessels does not influence the primary patency of primarily stented femoral and
popliteal arteries. TASC II classification appears to be significantly more predictive of initial failure after angioplasty and
stenting of these vessels. ( J Vasc Surg 2012;55:994-1000.)
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8Peripheral arterial disease is a significant problem in the
United States, affecting nearly 12% of the adult population
aged 55 years.1 The traditional treatment of lower ex-
tremity ischemia has been open bypass grafting. During the
past decade, however, angioplasty and stent placement has
become an accepted first-line treatment for certain infrain-
guinal arterial lesions. Nitinol stenting of superficial femo-
ral artery (SFA) and popliteal artery (PA) lesions, either
primarily or secondarily, has been common.
Endovascular treatment of iliac lesions approaches the
durability of open surgery,2 but the same has not been
proven for percutaneous intervention of infrainguinal le-
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994ions. High rates of restenosis have plagued patients after
ngioplasty and stenting of SFA and PA lesions.3,4 Clearly,
he identification of factors associated with failure of per-
utaneous procedures in these patients is important. Hy-
ertension, diabetes, and renal failure have been associated
ith diminished primary patency after percutaneous
ransluminal angioplasty (PTA) and stent placement.5 In
ddition, TransAtlantic Inter-Society (TASC) II classifica-
ion has been significantly correlated with the durability of
atheter-based infrainguinal interventions.6
Several studies have demonstrated that the number of
unoff vessels does influence outcomes in patient popula-
ions undergoing PTA alone and those having selective
tent placement for the treatment of infrainguinal occlusive
isease.5,7,8 However, the effect of tibial vessel runoff on
rimarily stented SFA and PA lesions is less well defined.
ur objective was to determine whether the number of
atent tibial runoff vessels affects patency of primarily
tented SFA and PA segments.
ETHODS
After approval by the Institutional Review Board, the
ecords of all patients undergoing angioplasty and nitinol
tenting of the SFA and PA at a single institution during an
4-month period were reviewed. During the time of this
tudy, all diseased SFA and PA segments were primarily
(
a
(
m
s
e
a
t
S
o
s
t
r
p
m
t
m
p
t
m
t
a
P
R
a
s
w
p
(
y
t
u
f
f
f
d
i
, haz
JOURNAL OF VASCULAR SURGERY
Volume 55, Number 4 Lee and Katz 995stented. All procedures were performed by or under the
direct supervision of one vascular surgeon (S.G.K.). For
reasons previously discussed,6 no attempts were made to
perform percutaneous intervention on patients with orifi-
cial or total occlusion of the SFA, PA, and proximal tibial
arteries. These patients were preferentially treated with
bypass surgery. The study excluded patients who received
covered stents or if they were lost to follow-up before a
repeat arterial duplex ultrasound scan was performed after
stent placement. Data collected included patient sex, de-
mographics, comorbidities, smoking history, and use of
warfarin anticoagulation. Indication for intervention and
location and severity of SFA and PA lesions were recorded
on a per-limb basis.
For the purposes of statistical analysis, two different
scoring systems were used, and patients were placed into
two groups: those with good runoff and those with com-
promised runoff. In the first scoring system, the number of
patent tibial vessels was determined by angiography and
was scored as 0, 1, 2, or 3. Patients were placed into two
groups: those with zero or one patent tibial vessels (com-
promised runoff) and those having two or three patent
vessels (good runoff) per Society for Vascular Surgery
(SVS) guidelines.9 A vessel was considered patent if it had
50% stenosis and was continuous down to the level of the
ankle. The second system was a modification of the SVS
runoff score in which each tibial vessel was given a maxi-
mum of 3 points (0 to 9 total per limb).10 Limbs with a
runoff score of 0 to 5 were considered to have good runoff,
and those with scores5 were considered to have compro-
mised runoff.10 Runoff scores were based on completion
arteriography to detect any distal embolization or change in
tibial vessel status after the intervention. Complications,
including hematoma requiring transfusion, surgery, or
change in level of care, clinical myocardial infarction sub-
stantiated by elevated troponin levels, amputation, and
death, were recorded.
All angioplasty and stent procedures were performed in
an angiography suite with fixed imaging. Our methods of
intervention have previously been described.6 Stent selec-
tion was based on availability and surgeon preference.
When multiple stents were deployed over a single lesion,
there was an overlap of 1 cm between them. For occlusions
Table I. Risk factors as assessed by univariate Cox proport
Patients, No (%
Risk factors (N  236)
Hypertension 215 (91.1)
Hypercholesterolemia 126 (53.4)
Coronary artery disease 125 (53)
Diabetes mellitus 106 (44.9)
COPD 39 (16.5)
End-stage renal disease 14 (5.9)
Active smoking 58 (24.6)
Warfarin anticoagulation 16 (6.8)
CI, Confidence interval; COPD, chronic obstructive pulmonary disease; HRmeasuring 5 cm, a subintimal approach was often used. tPatients received clopidogrel (300 mg) and aspirin
325 mg) before their procedures. After the intervention,
ll patients received a minimum of a 30-day course of Plavix
75 mg; Sanofi-Aventis, Bridgewater, NJ) and aspirin (81
g) daily. Heparin (5000 U) was given before PTA and
tent placement. Anticoagulation was not reversed at the
nd of the procedure. Successful intervention was defined
s 30% residual stenosis in the treated vessel.
Patients underwent arterial duplex scans at 30 days after
heir intervention and at 6-month intervals thereafter. Per
VS guidelines, loss of primary patency was defined as stent
cclusion or development of a50% stenosis in the stented
egment.9 A 50% stenosis was identified when a peak sys-
olic velocity of 200 cm/s developed and a 3:1 velocity
atio was seen across the lesion. The duration of primary
atency was recorded and used to determine outcome
easures for survival curves.
Univariate analysis was performed on factors poten-
ially influencing primary stent patency. Comparisons were
ade between patients who did and did not lose primary
atency. Kaplan-Meier tables were calculated on an intent-
o-treat basis, and differences were tested by the log-rank
ethod. Categoric factors were compared using a two-
ailed Fisher exact test. Statistical significance was assumed
t P  .05. Statistical calculations were performed using
ASW 18.0 software (IBM Corp, Armonk, NY).
ESULTS
Between January 2004 and December 2010, 316 PTA
nd infrainguinal stent procedures were performed. The
tudy excluded 26 patients undergoing 27 procedures who
ere lost to follow-up, leaving 289 interventions in 236
atients, comprising 128 women (54.2%) and 108 men
45.8%). Mean patient age was 76.2 years (range, 37-97
ears). Patient risk factors are listed in Table I. None of
hese were found to significantly affect stent patency on
nivariate analysis.
A total of 172 interventions (59.5%) were performed
or claudication, 51 (17.6%) for rest pain, and 66 (22.8%)
or tissue loss, defined as open ulcers or gangrene. Mean
ollow-up was 449 days (range, 3-2357 days; median, 308
ays). There were 141 isolated SFA lesions (48.8%), 53
solated PA lesions (18.3%), and 95 (32.9%) involved both
l hazards model
HR (95% CI) P
1.105 (0.509-2.397) .801
0.905 (0.598-1.37) .637
1.428 (0.941-2.169) .094
1.191 (0.773-1.836) .427
1.506 (0.85-2.667) .161
1.362 (0.586-3.168) .473
1.064 (0.678-1.671) .787
0.799 (0.292-2.185) .662
ard ratio.iona
)he SFA and PA. The above-knee PA was solely affected in
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April 2012996 Lee and Katz38 cases (13.1%), nine lesions (3.1%) involved only the
below-knee PA, and six (1%) involved both above- and
below-knee segments. Eighty-one lesions were classified as
TASC A (28%), 121 as TASC B (41.9%), 50 as TASC C
(17.3%), and 37 as TASC D (12.8%).
Distal runoff was good (two or three vessels) in 144
limbs (49.8%) and poor (zero or one vessel) in 145 limbs
(50.2%). There were zero runoff vessels in 14 limbs (4.8%),
one vessel in 131 limbs (45.3%), two vessels in 88 limbs
(30.4%), and three vessels in 56 limbs (19.4%). The differ-
ent combinations of runoff vessels are reported in Table II.
The identity of the specific tibial runoff vessels did not
significantly affect primary patency of stents (P  .24).
Fifteen patients underwent concomitant tibial angioplasty,
Fig 1. Primary patency grouped by TransAtlantic Inter-Society
Consensus (TASC) A and B vs C and D lesions.
Months 0 20 40 60
Number at risk (TASC A, B) 202 31 7 1
Number at risk (TASC C, D) 87 18 3 1
Table II. Runoff vessels
Limbs
Runoff vessels No. (%)
None 14 (4.8)
Anterior tibial only 41 (14.2)
Posterior tibial only 33 (11.4)
Peroneal only 57 (19.7)
Anterior tibial  posterior tibial  peroneal 56 (19.4)
Peroneal  anterior tibial 26 (9)
Peroneal  posterior tibial 34 (11.8)
Anterior tibial  posterior tibial 28 (9.7)converting them from zero to one runoff vessel. aPrimary patency was lost in 90 stented arteries. Stent
ailure was secondary to hemodynamically significant ste-
osis in 55 and occlusion in 35. Overall primary patency
ates at 12, 24, and 36 months were 70.3%, 52.4%, and
9.1%, respectively. Limbs with TASC A or B lesions had
ignificantly better patency rates than those with TASC C
r D lesions (P  .001). The Kaplan-Meier curve is de-
icted in Fig 1. Stent durability was also increased when
laced in patients who presented with claudication as op-
osed to rest pain or tissue loss (P  .038).
Table III, A reports the number of limbs with good or
ompromised runoff for each of the two scoring systems
ithin each TASC class. There was no difference in primary
atency of stents in limbs with poor runoff vs those with
ood runoff (P  .355; Fig 2). This did not change when
e further separated runoff into zero, one, two, or three
atent tibial vessels (P  .799; Fig 3). There was also no
orrelation between primary patency and runoff status us-
ng the modified SVS runoff score (P  .79; Fig 4).
lthough the number of runoff vessels decreased with
orsening TASC class (P  .024), overall and within each
ASC class, there was no difference in the primary patency
f stented segments with good or compromised runoff
sing either of the two scoring systems (Table III, B).
imilarly, there was no difference in the rate of stent occlu-
ion in limbs with poor vs good runoff (P  .383).
Stents placed in limbs with disease confined to the SFA
ad significantly higher primary patency rates than those
ith PA or combined SFA and PA disease (P .004). The
rimary patency of PA stents was 73.6% overall and 77.8%
or those placed below the knee. Within each anatomic
ocation (SFA, PA, or combined), there was no significant
able III. Comparison of primary patency based on
unoff (good vs compromised) within TransAtlantic
nter-Society Consensus (TASC) class using (A) the
umber of tibial runoff vessels and (B) the modified
ociety for Vascular Surgery (SVS) score
, Tibial vessel runoff
No. of patients
TASC classification 2 or 3 vessels 0 or 1 vessel Total P
46 35 81 .57
66 55 121 .126
20 30 50 .764
12 25 37 .31
otal 144 145 289 . . .
, Modified SVS score
No. of patients
TASC classification 0-5 5 Total P
45 36 81 .379
58 63 121 .092
17 33 50 .559
10 27 37 .153
otal 130 159 289 . . .ssociation between stent patency and runoff status (P 
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Volume 55, Number 4 Lee and Katz 997.126 for each). The location of infrainguinal disease did not
significantly correlate with compromised vs good runoff
(P .574). This did not change when runoff was separated
into zero, one, two, or three tibial vessels (P  .975). The
effect of the initial number of patent runoff vessels on
amputation rates approached but did not achieve statistical
significance (P  .063). Initial TASC class affected limb
salvage, and limbs with TASC C or D lesions were signifi-
cantly more likely to require later amputation than those
with TASC A or B lesions (P  .036).
During the study period, 10 major amputations were
performed in patients who initially presented with critical
limb ischemia. Six of these patients had progressive tissue
loss or uncontrolled wound sepsis despite patent stents.
The other four patients had stent failure with occlusion,
one of whom had a TASC C lesion at initial presentation,
and the remaining three had TASCD lesions. Limb salvage
in patients with critical limb ischemia was 91.5%.
Nine patients (3.1%) developed significant hematomas
requiring transfusion, two patients (0.6%) sustained clinical
myocardial infarctions with elevated cardiac enzymes, and
one patient (0.3%) required thrombolysis for a distal em-
bolus. One death occurred secondary to myocardial infarc-
tion 3 weeks after PTA with stenting.
DISCUSSION
As the population ages, peripheral arterial disease will
Fig 2. Primary patency vs good (two or three vessel) vs poor (zero
or one vessel) runoff
Months 0 20 40 60
Number at risk with 0 or 1 vessel runoff 202 28 4 0
Number at risk with 2 or 3 vessel runoff 87 22 6 3continue to become a progressively more significant prob- aem, placing an increasing burden on our health care sys-
em. In recent years, PTA with or without stenting has
ecome the first-line treatment for many patients with iliac,
emoral, and PA lesions.11 Advantages of catheter-based pro-
edures include decreasedmorbidity, shortenedhospital stays,
nd widespread patient acceptance.4,12 In addition, initial
ailure can often be salvaged by repeat percutaneous interven-
ion. The major disadvantage of endovascular procedures is
he relatively low rate of primary patency and the necessity
f often requiring multiple interventions to achieve a satis-
actory and lasting result.2,4 Because these procedures re-
uire significant resources and do carry some risk, it is
mportant to identify the factors that influence the durabil-
ty of these interventions.
Primary patency, as defined by the SVS, was chosen as
ur outcomemeasure because it is a stringent measurement
ool and an objective indicator of the durability of various
nterventions. It allows for accurate comparisons of differ-
nt procedures and the effect of risk factors on stent failure.
ecause it is not operator dependent, it is unlikely to be
nfluenced by physician bias and allows for objective data
nalysis. We began primary stenting of all femoral and
opliteal lesions as part of a prospective study and have
ontinued that practice to the present time. Runoff was
alculated in two ways. The simpler classification of runoff,
Fig 3. Primary patency vs number of runoff vessels
onths 0 20 40 60
umber at risk with 0 runoff vessels 14 0 0 0
umber at risk with 1 runoff vessel 131 28 4 0
umber at risk with 2 runoff vessels 88 14 4 1
umber at risk with 3 runoff vessels 56 8 2 0s defined by the SVS (two or three patent tibial vessels as
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April 2012998 Lee and Katzgood runoff vs zero or one patent tibial vessel as poor
runoff), is easily calculated and frequently used by those
performing catheter-based interventions as an alternative to
the more detailed SVS runoff score.9 We also used a more
detailed modified SVS runoff score, as outlined in the
Methods section.10 It is interesting to note that using the
two scoring systems, there was a 97% correlation between
those with good runoff vs those with compromised runoff.
Previously, hypertension, hypercholesterolemia, diabe-
tes, dialysis-dependent renal failure, and the use of warfarin
anticoagulation have been shown to negatively affect the
primary patency of limbs undergoing PTA with or without
stenting.5 Other factors, such as indication for interven-
tion, plaque morphology, and the degree of residual steno-
sis after PTA, have been shown to affect outcome after
intervention.9,13 Iliac interventions have proven to bemore
durable than those performed on infrainguinal vessels.14
Some have maintained that interventions of the SFA were
no more durable than those performed on the PA.15
In contrast, we found that SFA lesions were more likely
to remain patent after primary stenting than were lesions in
the PA. Initial TASC classification has been shown to be a
significant predictor of primary patency after PTA and
stenting of the SFA and PAs.6 Stents placed across TASC A
and B lesions have significantly more durable outcomes
than those classified as TASC C or D. Our results are
Fig 4. Primary patency vs modified Society of Vascular Surgery
(SVS) runoff score of 0 to 5 or 5
Months 0 20 40 60
Number at risk with runoff score 0-5 130 19 4 1
Number at risk with runoff score 5 159 30 4 1consistent with these findings. We previously reported a p3.5% rate of reintervention and found that it was significantly
igher in patients with TASCC andD lesions than those with
ASC A and B lesions.16 However, reintervention rates did
ot correlate with runoff status. We chose to intervene on
ymptomatic patients with an intrastent stenosis of50% and
n those asymptomatic patients with peak systolic velocities of
350 cm/s or velocity ratios4:1 across the lesion.We have
reviously found that a significant number of patients losing
rimary patency had lost runoff vessels on subsequent arte-
iography or duplex examination.
Although it is widely accepted that the most important
actor influencing patency of lower extremity bypass grafts
s the quality of the autogenous conduit, the effect of runoff
n the durability of open surgical bypass remains unclear.17
everal studies demonstrated that poor runoff does not
ffect the durability of prosthetic infrainguinal bypass
rafts.18,19 However, el-Massry et al20 found that runoff
as the single most significant predictor of prosthetic fem-
ropopliteal graft failure. Another study, including a mixed
roup of patients receiving prosthetic and autogenous by-
ass grafts, showed that runoff significantly influenced graft
atency.21 Brewster et al22 found that runoff affected au-
ogenous vein graft patency but had minimal effects on
rosthetic grafts. Seeger et al23 concluded that runoff is of
ajor importance in the outcome of infrainguinal bypass
rafts using autogenous vein because 70% of patients in his
eries with compromised runoff required amputation, sus-
ained graft occlusion, or died.3 Another study failed to find
definite correlation between autogenous graft patency
nd the quality of distal runoff.24
A number of authors studying infrainguinal angio-
lasty alone have found that runoff status significantly
ffects the success of these endovascular interven-
ions.14,25 The effect of runoff on stented femoral and
opliteal vessels is less clear. Several studies demonstrat-
ng a relationship between compromised runoff and poor
utcomes included limbs undergoing angioplasty alone
s well as those that were stented.7,8 Ihnat et al26 dem-
nstrated that poor runoff scores correlated with de-
reased patency rates of stented SFAs. However, patients
n their series were selectively stented and included those
eceiving expanded polytetrafluoroethylene covered
tents. In contrast, patients in our series were primarily
tented using only bare nitinol stents.
Several studies have evaluated primary stenting of the
emoral and popliteal vessels.4,27 Although the number of
unoff vessels was recorded, the relationship between tibial
essel patency and stent durability was not analyzed. One
mall series found no correlation between runoff and stent
atency.15 In our present study, only initial TASC II clas-
ification and placement of stents in the SFA alone directly
orrelated with primary stent patency. In each arterial seg-
ent in which stents were placed (SFA, PA, or SFA and
A), no relationship was found between runoff and primary
tent patency. We found it interesting that although the
umber of patent tibial vessels declined as TASC classifica-
ion worsened, this did not account for the difference in
atency rates between stents placed in limbs with TASC A
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We were also able to demonstrate that primarily stented
segments of the SFA and PA with poor runoff were no
more likely to fail with occlusion than their counterparts
with two or three patent tibial vessels.
A number of factors, including dialysis-dependent renal
failure and female sex, have been shown to be predictors of
limb loss after endovascular intervention.5Compromised run-
off also significantly correlated with decreased limb salvage
rates.5,8 The effect of the number of initially patent tibial
vessels on limb salvage in our series approached but did not
achieve statistical significance (P .063). This may have been
due to the small number of patients who underwent major
amputation. Overall limb salvage in our patients with critical
limb ischemiawas 91.5%,which is consistentwith limb salvage
rates reported by other authors.8,28
CONCLUSIONS
When primary nitinol stenting is used in the treatment
of SFA and PA lesions, the number of patent tibial vessels
does not affect primary patency. Runoff need not be of
prime consideration when attempting to predict the dura-
bility of these percutaneous interventions. At present,
TASC II classification at the time of initial intervention
appears to remain the most important determinant of pa-
tency after primary stenting of the SFA and PAs.
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Dr Ahmed M. Abou-Zamzam, Jr (Loma Linda, Calif). I
would like to congratulate the authors on a nice presentation and
a well-written manuscript. This single-center, retrospective study
seeks to analyze the effect of tibial runoff on outcomes following
primary stenting of superficial femoral (SFA) and popliteal artery
disease. In a retrospective study of nearly 300 cases performed over
7 years, the authors have found that tibial runoff does not appear to
influence overall outcomes. Primary patency and limb salvage were
equivalent in patients with zero or one patent tibial arteries com-
pared to patients with two or three patent tibial arteries. Not
surprisingly, the Trans-Atlantic InterSociety (TASC) II classifica-
tion did predict outcome. These results agree to some degree with
numerous reports in the literature and add to the growing, and
confusing, data regarding percutaneous treatment of infrainguinal
disease. The one take-home message I can agree with is that TASC
II classification trumps outflow. I have four questions:
First, the authors have chosen to use the simplified tibial
runoff scoring system. This is pretty much a yes/no score for each
runoff vessel. At this meeting 4 years ago, the Tucson group
reported, using the more complex Society for Vascular Surgery
(SVS) scoring system, that runoff did influence outcome following
SFA stenting. Why the discrepancy in this report? Did you analyze
your data with the more complete scoring system?
Second, you have adopted a policy of primary stenting. This
study spans 7 years and undoubtedly numerous stent types. Every-
one by now has their favorite stents for the SFA.What stent did you
use, and why? Did you look at outcomes by stent types? Also, this
study included no covered stents. Do you use them?
m
yThird, your study includes a predominance of patients with
laudication. We might understand caution in treating tibial dis-
ase in patients with claudication. However, when treating limb
hreat, isn’t it tempting to intervene? Groups have suggested that if
ibial outflow is compromised, perhaps results of SFA/popliteal
nterventions would be improved with tibial interventions. When
hould tibial interventions be performed?
Fourth, finally, did you do an analysis of primary assisted and
econdary patency? How are these affected by runoff?
I enjoyed the presentation and manuscript and look forward
o your responses. Thank you
Dr Jenny J. Lee. Dr Abou-Zamzam, thank you for your
nsightful comments and thoughtful questions. I will attempt to
nswer them in order. Our data were recently reanalyzed utilizing
modified SVS scoring system and we found that runoff did not
ffect primary patency rates using either scoring method. We
urrently employ a number of different nitinol stents and have
ound them all, with the exception of the Luminexx stent, to
erform in a similar fashion. At present, we currently use covered
tents infrequently, most often as a treatment for repetitive intras-
ent stenosis. Tibial intervention was performed concurrently in
bout 6% of our patients, all of whom had tissue loss or gangrene.
unoff was graded based upon completion arteriography. In an-
wer to your final question, the focus of our paper was on primary
atency rates, and primary assisted and secondary patency rates
ere not calculated. I would like to thank the society for allowing
e to present our work and for the privilege of the floor. Thank
ou.
